U.S. Customs Announces New Tariff Classifications Affecting Pharmaceutical Imports
In a recent announcement, the U.S. Customs and Border Protection (CBP) detailed new tariff classifications that will impact the pharmaceutical industry significantly. Beginning Friday, pharmaceutical companies will not face immediate tariff rates up to 100% on certain imported patented drugs and ingredients. However, the new regulations require importers to begin classifying their goods in preparation…